Earnings Review
During the quarter, manufacturing costs increased 18.9% year over year to R$1,784.8 million (US$991.6 million). Loans, financing and debentures, net of current portion were R$16,472.4 million (US$9,151.3 million), up 12.2% from R$14,684.5 million (US$8,158.1 million) in the previous quarter.
Detailed discussion on the earnings release can be found here: CSN’s Profit Soars, Equals Estimate
Agreement of Analysts
Magnitude of Estimate Revisions
Underperform Recommendation
Considering these factors and anticipating a lack of any positive share price driver, we rate the ADR Underperform.
CIA SIDERUR-ADR (SID
Zacks Investment Research
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
